Binding to DNA of the RNA-polymerase II C-terminal domain allows discrimination between Cdk7 and Cdk9 phosphorylation

Nucleic Acids Research

Volumn 37, Issue 4, 2009, Pages 1260-1268

  Lolli, Graziano ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 9; DNA; RNA POLYMERASE II; SERINE; TRANSCRIPTION ELONGATION FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISSOCIATION; DNA PROTEIN COMPLEX; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; BINDING SITES; CYCLIN-DEPENDENT KINASE 9; CYCLIN-DEPENDENT KINASES; DNA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RNA POLYMERASE II;

EID: 62549094029     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn1061     Document Type: Article

References (42)

1. Hirose,Y. and Manley,J.L. (2000) RNA polymerase II and the integration of nuclear events. Genes Dev., 14, 1415-1429.
2. Usheva,A., Maldonado,E., Goldring,A., Lu,H., Houbavi,C., Reinberg,D. and Aloni,Y. (1992) Specific interaction between the nonphosphorylated form of RNA polymerase II and the TATA-binding protein. Cell, 69, 871-881.
3. Myers,L.C. and Kornberg,R.D. (2000) Mediator of transcriptional regulation. Annu. Rev. Biochem., 69, 729-749.
4. Yue,Z., Maldonado,E., Pillutla,R., Cho,H., Reinberg,D. and Shatkin,A.J. (1997) Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II. Proc. Natl Acad. Sci. USA, 94, 12898-12903.
5. McCracken,S., Fong,N., Rosonina,E., Yankulov,K., Brothers,G., Siderovski,D., Hessel,A., Foster,S., Shuman,S. and Bentley,D.L. (1997) 5′-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev., 11, 3306-3318.
6. Kobor,M.S. and Greenblatt,J. (2002) Regulation of transcription elongation by phosphorylation. Biochim. Biophys. Acta, 1577, 261-275.
7. Oelgeschlager,T. (2002) Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control. J. Cell. Physiol., 190 160-169.
8. Wada,T., Takagi,T., Yamaguchi,Y., Watanabe,D. and Handa,H. (1998) Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J., 17, 7395-7403.
9. Ivanov,D., Kwak,Y.T., Guo,J. and Gaynor,R.B. (2000) Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol., 20, 2970-2983.
10. Kim,J.B. and Sharp,P.A. (2001) Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase. J. Biol. Chem., 276, 12317-12323.
11. Fujinaga,K., Irwin,D., Huang,Y., Taube,R., Kurosu,T. and Peterlin,B.M. (2004) Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol., 24, 787-795.
12. Otero,G., Fellows,J., Li,Y., de Bizemont,T., Dirac,A.M., Gustafsson,C.M., Erdjument-Bromage,H., Tempst,P. and Svejstrup,J.Q. (1999) Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation. Mol. Cell, 3, 109-118.
13. Shilatifard,A., Conaway,R.C. and Conaway,J.W. (2003) The RNA polymerase II elongation complex. Annu. Rev. Biochem., 72, 693-715.
14. Corden,J.L. and Patturajan,M. (1997) A CTD function linking transcription to splicing. Trends Biochem. Sci., 22, 413-416.
15. McCracken,S., Fong,N., Yankulov,K., Ballantyne,S., Pan,G., Greenblatt,J., Patterson,S.D., Wickens,M. and Bentley,D.L. (1997) The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature, 385, 357-361.
16. Peterlin,B.M. and Price,D.H. (2006) Controlling the elongation phase of transcription with P-TEFb. Mol. Cell, 23, 297-305.
17. Hirose,Y. and Ohkuma,Y. (2007) Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression. J. Biochem., 141, 601-608.
18. Lolli,G., Lowe,E.D., Brown,N.R. and Johnson,L.N. (2004) The crystal structure of human CDK7 and its protein recognition properties. Structure, 12, 2067-2079.
19. Baumli,S., Lolli,G., Lowe,E.D., Troiani,S., Rusconi,L., Bullock,A.N., Debreczeni,J.E., Knapp,S. and Johnson,L.N. (2008) The structure of P-TEFb, its complex with flavopiridol and regulation by phosphorylation. EMBO J., 27, 1907-1918.
20. Brown,N.R., Noble,M.E., Endicott,J.A. and Johnson,L.N. (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell. Biol., 1, 438-443.
21. Khiat,A., Lamoureux,M. and Boulanger,Y. (1996) Structural differences between the free and bound states of the DNA-bisintercalating peptide YSPTSPSY. J. Med. Chem., 39, 2492-2498.
22. Dominguez,C., Boelens,R. and Bonvin,A.M. (1993) HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc., 125, 1731-1737.
23. de Vries,S.J., van Dijk,A.D., Krzeminski,M., van Dijk,M., Thureau,A., Hsu,V., Wassenaar,T. and Bonvin,A.M. (2007) HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69, 726-733.
24. Suzuki,M. (1990) The heptad repeat in the largest subunit of RNA polymerase II binds by intercalating into DNA. Nature, 344, 562-565.
25. Huang,X., Shullenberger,D.F. and Long,E.C. (1994) Aromatic stacking and bending of the DNA helix by the individual repeat units of the carboxy-terminal domain of RNA polymerase II. Biochem. Biophys. Res. Commun., 198, 712-719.
26. Trigon,S., Serizawa,H., Conaway,J.W., Conaway,R.C., Jackson,S.P. and Morange,M. (1998) Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases. J. Biol. Chem., 273, 6769-6775.
27. Rickert,P., Corden,J.L. and Lees,E. (1999) Cyclin C/CDK8 and cyclin H/ CDK7/p36 are biochemically distinct CTD kinases. Oncogene, 18 1093-1102.
28. Zhou,M., Halanski,M.A., Radonovich,M.F., Kashanchi,F., Peng,J., Price,D.H. and Brady,J.N. (2000) Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol., 20, 5077-5086.
29. Addess,K.J. and Feigon,J. (1994) Sequence specificity of quinoxaline antibiotics. 1. Solution structure of a 1:1 complex between triostin A and [d(GACGTC)]2 and comparison with the solution structure of the [N-MeCys3,N-MeCys7]TANDEM-[d(GATATC)]2 complex. Biochemistry, 33, 12386-12396.
30. Wang,A.H., Ughetto,G., Quigley,G.J., Hakoshima,T., van der Marel,G.A., van Boom,J.H. and Rich,A. (1984) The molecular structure of a DNA-triostin A complex. Science, 225, 1115-1121.
31. Wang,A.H., Ughetto,G., Quigley,G.J. and Rich,A. (1986) Interactions of quinoxaline antibiotic and DNA: The molecular structure of a triostin A-d(GCGTACGC) complex. J. Biomol. Struct. Dyn., 4, 319-342.
32. Krissinel,E. and Henrick,K. (2007) Inference of macromolecular assemblies from crystalline state. J. Mol. Biol., 372, 774-797.
33. Yankulov,K.Y. and Bentley,D.L. (1997) Regulation of the CDK7 substrate specificity by MAT1 and TFIIH. EMBO J., 16, 1638-1646.
34. Lolli,G. and Johnson,L.N. (2007) Recognition of Cdk2 by Cdk7. Proteins, 67, 1048-1059.
35. Peterson,C.L., Kruger,W. and Herskowitz,I. (1991) A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1. Cell, 64, 1135-1143.
36. Chapman,R.D., Heidemann,M., Albert,T.K., Mailhammer,R., Flatley,A., Meisterernst,M., Kremmer,E. and Eick,D. (2007) Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science, 318, 1780-1782.
37. Egloff,S., O'Reilly,D., Chapman,R.D., Taylor,A., Tanzhaus,K., Pitts,L., Eick,D. and Murphy,S. (2007) Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression. Science, 318 1777-1779.
38. Baskaran,R., Escobar,S.R. and Wang,J.Y. (1999) Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: Possible role in transcription elongation. Cell Growth Differ., 10, 387-396.
39. Ramanathan,Y., Rajpara,S.M., Reza,S.M., Lees,E., Shuman,S., Mathews,M.B. and Pe'ery,T. (2001) Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J. Biol. Chem., 276, 10913-10920.
40. Pinhero,R., Liaw,P., Bertens,K. and Yankulov,K. (2004) Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II. Eur. J. Biochem., 271, 1004-1014.
41. Douziech,M., Forget,D., Greenblatt,J. and Coulombe,B. (1999) Topological localization of the carboxyl-terminal domain of RNA polymerase II in the initiation complex. J. Biol. Chem., 274, 19868-19873.
42. Marshall,N.F., Peng,J., Xie,Z. and Price,D.H. (1996) Control of RNA polymerase II elongation potential by a novel carboxylterminal domain kinase. J. Biol. Chem., 271, 27176-27183.